Skip to main content
. Author manuscript; available in PMC: 2008 Sep 30.
Published in final edited form as: Biochemistry. 2007 Jun 20;46(28):8392–8400. doi: 10.1021/bi700289k

Figure 2. SDS-PAGE and Western blot analyses of unmodified and acrolein-modified apoE3-NT.

Figure 2

ApoE3-NT (50 μM) was incubated without or with 0.5 mM acrolein for 4 h at 37 °C. Unmodified and acrolein-modified apoE3-NT (lanes 1 and 2, respectively) were analyzed by SDS-PAGE (Panel A) and Western blot using anti-apoE antibody mAb1D7 (Panel B) or anti-acrolein-lysine antibody mAb5F6 (Panel C).

HHS Vulnerability Disclosure